Faculdade de Medicina, Centro Universitario Saude ABC, Santo Andre, Sao Paulo, SP, Brazil.
Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California San Diego, San Diego, USA.
Clin Rev Allergy Immunol. 2021 Aug;61(1):60-65. doi: 10.1007/s12016-021-08852-7. Epub 2021 Mar 23.
Hereditary angioedema (HAE) is an autosomal dominant disease mostly due to the deficiency of C1 inhibitor (C1-INH). HAE with normal C1-INH was first described in 2000 and associated with mutations in the coagulation factor XII in 2006. Both diseases are associated with high bradykinin production, resulting in increased vascular permeability. Gastrointestinal edema due to HAE can be misdiagnosed as acute abdomen and unnecessary surgical procedures may be performed. The present study evaluates the prevalence of surgical procedures and/or acute abdomen in HAE patients with the coagulation factor XII mutation. It is a retrospective study where patients were diagnosed with recurrent angioedema without urticaria, normal C1-INH levels, and positive family history of angioedema. All patients were evaluated for the known mutations located at exon 9 of the F12 gene. Medical records were evaluated and questionnaires were applied to 52 patients with normal C1-INH levels (age range 13-76 years; 47/52, 90.38% women; 5/52, 9.61% men). F12 mutation was present in 32/52 patients (61.5%). Acute abdominal pain was diagnosed in 16/52 (30.76%) patients, appendicitis in 9/16 (56.2%), and undetermined diagnosis in 7/16 (43.7%). Among patients diagnosed with acute abdominal pain, 13/16 (81.2%) underwent surgery and 3/16 (18.7%) improved without surgical intervention. We conclude that many HAE patients with coagulation factor XII mutation were misdiagnosed with acute abdomen and subjected to unnecessary invasive procedures. It is critical to disseminate information about this rare mutation in patients with otherwise normal C1-INH activity, in order to speed up diagnosis and avoid misconduct.
遗传性血管性水肿(HAE)是一种常染色体显性疾病,主要由于 C1 抑制剂(C1-INH)缺乏所致。2000 年首次描述了 C1-INH 正常的 HAE,并于 2006 年与凝血因子 XII 的突变相关。这两种疾病均与高缓激肽产生相关,导致血管通透性增加。HAE 引起的胃肠道水肿可能被误诊为急腹症,从而导致不必要的手术。本研究评估了凝血因子 XII 突变的 HAE 患者中手术程序和/或急腹症的患病率。这是一项回顾性研究,研究对象为诊断为反复发作的血管性水肿但无荨麻疹、C1-INH 水平正常且有血管性水肿阳性家族史的患者。所有患者均接受了位于 F12 基因外显子 9 的已知突变的评估。评估了病历并对 52 名 C1-INH 水平正常的患者(年龄范围为 13-76 岁;47/52,90.38%为女性;5/52,9.61%为男性)进行了问卷调查。在 52 名患者中,F12 突变存在于 32 名(61.5%)患者中。52 名患者中有 16 名(30.76%)诊断为急性腹痛,其中 9 名(56.2%)为阑尾炎,7 名(43.7%)为未确定诊断。在诊断为急性腹痛的患者中,13 名(81.2%)接受了手术,3 名(18.7%)未经手术干预即有所改善。我们的结论是,许多凝血因子 XII 突变的 HAE 患者被误诊为急腹症,并接受了不必要的侵入性操作。在 C1-INH 活性正常的情况下,传播有关这种罕见突变的信息至关重要,以便加快诊断并避免不当行为。